Bal Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Profit before tax

5.73

12.11

8.55

12.06

9.80

Net cashflow-operating activity

20.31

28.95

5.07

31.48

10.24

Net cash used in investing activity

-14.90

-18.43

-22.08

-13.43

-6.66

Netcash used in fin. activity

-7.83

-7.71

17.43

-18.13

-3.36

Net inc/dec in cash and equivlnt

-2.42

2.81

0.42

-0.08

0.21

Cash and equivalnt begin of year

4.06

1.23

0.81

0.89

0.68

Cash and equivalnt end of year

1.64

4.04

1.23

0.81

0.89